Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pantoprazole After Prophylactic Endoscopic Variceal Treatment in Cirrhosis (PPEC)
NCT07248722Enrolling by invitation
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of pantoprazole in esophageal and gastric varices (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Proportion of Gastrointestinal Bleeding at 6 weeks. Started Mar 2026; status: enrolling by invitation.
02
Drugs
pantoprazole
03
Conditions
esophageal and gastric varices
Beyond the preview
Go deeper on NCT07248722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07248722.